Log in to save to my catalogue

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-n...

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-n...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2688867

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

About this item

Full title

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

Publisher

United States: National Acad Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (20), p.8368-8373

Language

English

Formats

Publication information

Publisher

United States: National Acad Sciences

More information

Scope and Contents

Contents

Triple-negative breast cancers (TNBCs) are defined by a lack of expression of estrogen, progesterone, and HER2 receptors. Because of the absence of identified targets and targeted therapies, and due to a heterogeneous molecular presentation, treatment guidelines for patients with TNBC include only conventional chemotherapy. Such treatment, while ef...

Alternative Titles

Full title

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2688867

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2688867

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0903392106

How to access this item